Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.

Front Chem

Biomolecular Sciences Research Group, School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.

Published: April 2022

The trypsin-like proteases (TLPs) play widespread and diverse roles, in a host of physiological and pathological processes including clot dissolution, extracellular matrix remodelling, infection, angiogenesis, wound healing and tumour invasion/metastasis. Moreover, these enzymes are involved in the disruption of normal lung function in a range of respiratory diseases including allergic asthma where several allergenic proteases have been identified. Here, we report the synthesis of a series of peptide derivatives containing an -alkyl glycine analogue of arginine, bearing differing electrophilic leaving groups (carbamate and triazole urea), and demonstrate their function as potent, irreversible inhibitors of trypsin and TLPs, to include activities from cockroach extract. As such, these inhibitors are suitable for use as activity probes (APs) in activity-based profiling (ABP) applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068901PMC
http://dx.doi.org/10.3389/fchem.2022.782608DOI Listing

Publication Analysis

Top Keywords

novel inhibitors
4
inhibitors activity-based
4
activity-based probes
4
probes targeting
4
targeting trypsin-like
4
trypsin-like serine
4
serine proteases
4
proteases trypsin-like
4
trypsin-like proteases
4
proteases tlps
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!